Literature DB >> 7054671

CSF rhinorrhea after bromocriptine for prolactinoma.

D S Baskin, C B Wilson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7054671     DOI： 10.1056/NEJM198201213060323

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  Medically induced CSF rhinorrhea following treatment of macroprolactinoma: case series and literature review.

Authors:  Tomáš Česák; Pavel Poczos; Jaroslav Adamkov; Jiří Náhlovský; Petra Kašparová; Filip Gabalec; Petr Čelakovský; Ondrej Choutka
Journal:  Pituitary       Date:  2018-12       Impact factor: 4.107

2.  Cabergoline-induced CSF rhinorrhea in patients with macroprolactinoma. Report of three cases.

Authors:  P Cappabianca; S Lodrini; G Felisati; C Peca; R Cozzi; A Di Sarno; L M Cavallo; S Giombini; A Colao
Journal:  J Endocrinol Invest       Date:  2001-03       Impact factor: 4.256

3.  Rhinorrhea following dopamine agonist therapy of invasive macroprolactinoma.

Authors:  G Hildebrandt; J Zierski; P Christophis; A Laun; H Schatz; I Lancranjan; N Klug
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

4.  Transnasal trans-sphenoidal endoscopic repair of CSF leak secondary to invasive pituitary tumours using a nasoseptal flap.

Authors:  B Thakur; A R Jesurasa; R Ross; T A Carroll; S Mirza; S Sinha
Journal:  Pituitary       Date:  2011-06       Impact factor: 4.107

5.  Efficacy and safety of cabergoline as first line treatment for invasive giant prolactinoma.

Authors:  Eun-Hee Cho; Sang Ah Lee; Ji Youn Chung; Eun Hee Koh; Young Hyun Cho; Jeong Hoon Kim; Chang Jin Kim; Min-Seon Kim
Journal:  J Korean Med Sci       Date:  2009-09-24       Impact factor: 2.153
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.